SLC5A2 and type 2 diabetes mellitus: Hence, the inhibition of renal SGLT2 was considered useful for treatment of T2DM, which was supported by studies with the natural compound phlorizin, a metabolically unstable and unspecific inhibitor of SGLT2 and SGLT13.